PIIIW Begin Period Cash Flow vs Net Income Analysis

PIIIW Stock

USD 0.01 0 11.88%

P3 Health financial indicator trend analysis is much more than just breaking down P3 Health Partners prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether P3 Health Partners is a good investment. Please check the relationship between P3 Health Begin Period Cash Flow and its Net Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Begin Period Cash Flow vs Net Income

Begin Period Cash Flow vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of P3 Health Partners Begin Period Cash Flow account and Net Income. At this time, the significance of the direction appears to have weak relationship.

The correlation between P3 Health's Begin Period Cash Flow and Net Income is 0.31. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Net Income in the same time period over historical financial statements of P3 Health Partners, assuming nothing else is changed. The correlation between historical values of P3 Health's Begin Period Cash Flow and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of P3 Health Partners are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Begin Period Cash Flow i.e., P3 Health's Begin Period Cash Flow and Net Income go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in P3 Health Partners financial statement analysis. It represents the amount of money remaining after all of P3 Health Partners operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from P3 Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into P3 Health Partners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At this time, P3 Health's Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.19 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 65.1 M in 2024.

	2020	2021	2023	2024 (projected)
Interest Expense	2.5M	2.5B	16.0M	15.2M
Depreciation And Amortization	795.2K	87.3K	86.7M	91.0M

Interest Expense Depreciation And Amortization

P3 Health fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Common Stock Shares Outstanding		0.25	0.56	0.6	0.6	0.36	0.77	-0.47	0.71	-0.79	0.23	-0.06	0.22	0.07	0.56	-0.06	0.68	0.65	0.55	0.66	-0.87	0.62	0.78	0.59	0.46	0.49
Total Assets	0.25		0.76	0.73	0.74	0.93	0.58	-0.73	0.17	-0.29	0.93	0.83	1.0	0.27	0.76	0.83	0.59	0.82	0.78	0.52	-0.16	0.58	0.73	0.76	0.95	0.79
Short Long Term Debt Total	0.56	0.76		1.0	0.99	0.65	0.79	-0.92	0.72	-0.8	0.82	0.32	0.75	0.57	1.0	0.32	0.96	0.95	1.0	0.91	-0.35	0.81	0.92	1.0	0.85	0.67
Other Current Liab	0.6	0.73	1.0		1.0	0.63	0.81	-0.9	0.75	-0.82	0.78	0.28	0.71	0.56	0.99	0.28	0.98	0.95	0.99	0.94	-0.4	0.81	0.93	1.0	0.84	0.64
Total Current Liabilities	0.6	0.74	0.99	1.0		0.65	0.81	-0.88	0.74	-0.82	0.77	0.29	0.72	0.56	0.99	0.29	0.97	0.96	0.99	0.94	-0.43	0.79	0.94	1.0	0.85	0.64
Total Stockholder Equity	0.36	0.93	0.65	0.63	0.65		0.71	-0.57	0.04	-0.2	0.77	0.87	0.92	-0.04	0.65	0.87	0.53	0.72	0.67	0.45	-0.33	0.59	0.68	0.66	0.95	0.84
Property Plant And Equipment Net	0.77	0.58	0.79	0.81	0.81	0.71		-0.69	0.52	-0.65	0.55	0.35	0.56	0.0	0.78	0.35	0.86	0.75	0.78	0.75	-0.59	0.89	0.81	0.81	0.79	0.79
Current Deferred Revenue	-0.47	-0.73	-0.92	-0.9	-0.88	-0.57	-0.69		-0.65	0.7	-0.9	-0.37	-0.71	-0.49	-0.93	-0.37	-0.87	-0.85	-0.94	-0.71	0.11	-0.88	-0.82	-0.9	-0.76	-0.76
Net Debt	0.71	0.17	0.72	0.75	0.74	0.04	0.52	-0.65		-0.98	0.33	-0.37	0.15	0.69	0.72	-0.37	0.81	0.7	0.7	0.84	-0.51	0.54	0.75	0.73	0.32	0.18
Retained Earnings	-0.79	-0.29	-0.8	-0.82	-0.82	-0.2	-0.65	0.7	-0.98		-0.41	0.24	-0.28	-0.62	-0.8	0.24	-0.88	-0.79	-0.78	-0.9	0.6	-0.63	-0.84	-0.81	-0.46	-0.32
Accounts Payable	0.23	0.93	0.82	0.78	0.77	0.77	0.55	-0.9	0.33	-0.41		0.7	0.92	0.41	0.83	0.7	0.66	0.82	0.85	0.53	0.02	0.71	0.73	0.8	0.86	0.8
Cash	-0.06	0.83	0.32	0.28	0.29	0.87	0.35	-0.37	-0.37	0.24	0.7		0.84	-0.22	0.33	1.0	0.13	0.39	0.36	0.01	0.1	0.35	0.3	0.31	0.73	0.74
Non Current Assets Total	0.22	1.0	0.75	0.71	0.72	0.92	0.56	-0.71	0.15	-0.28	0.92	0.84		0.28	0.75	0.84	0.57	0.8	0.77	0.51	-0.14	0.56	0.72	0.74	0.95	0.77
Non Currrent Assets Other	0.07	0.27	0.57	0.56	0.56	-0.04	0.0	-0.49	0.69	-0.62	0.41	-0.22	0.28		0.57	-0.22	0.5	0.55	0.56	0.63	-0.01	0.1	0.47	0.56	0.22	-0.13
Long Term Debt	0.56	0.76	1.0	0.99	0.99	0.65	0.78	-0.93	0.72	-0.8	0.83	0.33	0.75	0.57		0.33	0.96	0.95	1.0	0.9	-0.33	0.83	0.92	1.0	0.85	0.68
Cash And Short Term Investments	-0.06	0.83	0.32	0.28	0.29	0.87	0.35	-0.37	-0.37	0.24	0.7	1.0	0.84	-0.22	0.33		0.13	0.39	0.36	0.01	0.1	0.35	0.3	0.31	0.73	0.74
Net Receivables	0.68	0.59	0.96	0.98	0.97	0.53	0.86	-0.87	0.81	-0.88	0.66	0.13	0.57	0.5	0.96	0.13		0.89	0.95	0.94	-0.45	0.85	0.9	0.97	0.75	0.61
Good Will	0.65	0.82	0.95	0.95	0.96	0.72	0.75	-0.85	0.7	-0.79	0.82	0.39	0.8	0.55	0.95	0.39	0.89		0.95	0.88	-0.51	0.72	0.98	0.96	0.88	0.67
Non Current Liabilities Total	0.55	0.78	1.0	0.99	0.99	0.67	0.78	-0.94	0.7	-0.78	0.85	0.36	0.77	0.56	1.0	0.36	0.95	0.95		0.89	-0.32	0.83	0.92	0.99	0.86	0.69
Capital Lease Obligations	0.66	0.52	0.91	0.94	0.94	0.45	0.75	-0.71	0.84	-0.9	0.53	0.01	0.51	0.63	0.9	0.01	0.94	0.88	0.89		-0.57	0.64	0.88	0.93	0.69	0.39
Inventory	-0.87	-0.16	-0.35	-0.4	-0.43	-0.33	-0.59	0.11	-0.51	0.6	0.02	0.1	-0.14	-0.01	-0.33	0.1	-0.45	-0.51	-0.32	-0.57		-0.25	-0.63	-0.39	-0.36	-0.21
Other Current Assets	0.62	0.58	0.81	0.81	0.79	0.59	0.89	-0.88	0.54	-0.63	0.71	0.35	0.56	0.1	0.83	0.35	0.85	0.72	0.83	0.64	-0.25		0.74	0.8	0.72	0.86
Other Stockholder Equity	0.78	0.73	0.92	0.93	0.94	0.68	0.81	-0.82	0.75	-0.84	0.73	0.3	0.72	0.47	0.92	0.3	0.9	0.98	0.92	0.88	-0.63	0.74		0.93	0.84	0.68
Total Liab	0.59	0.76	1.0	1.0	1.0	0.66	0.81	-0.9	0.73	-0.81	0.8	0.31	0.74	0.56	1.0	0.31	0.97	0.96	0.99	0.93	-0.39	0.8	0.93		0.86	0.66
Net Invested Capital	0.46	0.95	0.85	0.84	0.85	0.95	0.79	-0.76	0.32	-0.46	0.86	0.73	0.95	0.22	0.85	0.73	0.75	0.88	0.86	0.69	-0.36	0.72	0.84	0.86		0.83
Property Plant And Equipment Gross	0.49	0.79	0.67	0.64	0.64	0.84	0.79	-0.76	0.18	-0.32	0.8	0.74	0.77	-0.13	0.68	0.74	0.61	0.67	0.69	0.39	-0.21	0.86	0.68	0.66	0.83

Click cells to compare fundamentals

P3 Health Account Relationship Matchups

P3 Health fundamental ratios Accounts

		2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding		47.6M	39.5M	41.6M	41.6M	294.6M	309.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PIIIW Begin Period Cash Flow vs Net Income Analysis

Begin Period Cash Flow vs Net Income

Begin Period Cash Flow vs Net Income Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Net Income

P3 Health fundamental ratios Correlations

P3 Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

P3 Health fundamental ratios Accounts

Also Currently Popular

Additional Tools for PIIIW Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Other Current Liab	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Total Current Liabilities	+ 1.0	Other Current Liab

Retained Earnings	- 0.98	Net Debt
Non Current Liabilities Total	- 0.94	Current Deferred Revenue
Long Term Debt	- 0.93	Current Deferred Revenue
Current Deferred Revenue	- 0.92	Short Long Term Debt Total
Capital Lease Obligations	- 0.9	Retained Earnings
Total Liab	- 0.9	Current Deferred Revenue